3 S&P 500 Stocks We’re Skeptical Of
about 9 hours agoThe S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But n...
NovaGold Q2 2026 Earnings Call Focuses on Donlin Progress
about 9 hours agoNG earnings call highlights steady Donlin Gold progress, feasibility study on track for H1 2027, strong liquidity and rising development spending.
JPMorgan names Doug Petno and Troy Rohrbaugh co-presidents as longtime exec Marianne Lake exits
about 9 hours agoCNBC's Leslie Picker reports on the latest news on JPMorgan.
Booking Holdings: Selloff May Be More Of An Opportunity Than Warning
about 9 hours agoBooking Holdings (BKNG) remains a high-quality travel platform, delivering robust cash flow and margins despite recent share price correction.
Is GSK Quietly Becoming An Oncology Powerhouse
about 9 hours agoGSK stock outlook: 3.46% dividend yield, 2026 core EPS growth guided at 7%â9%, and Exdensur as a new asthma growth driverâread the analysis now.
What to Expect From UnitedHealth Group's Q2 2026 Earnings Report
about 9 hours agoUnitedHealth Group Research is set to announce its second-quarter earnings next month, and Wall Street expects the company’s EPS to grow by double dig...
Micron soars on blowout quarter: AI boom fuels memory chip demand
about 9 hours agoCNBC’s Kristina Partsinevelos joins 'Squawk on the Street' with the latest news from Micron and Qualcomm.
Autodesk (ADSK) has fallen ~40% YTD, creating a compelling buying window due to resilient demand and improved fundamentals.
Chardan Capital analyst Andreas Argyrides maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and raises the price target from $21 to $23.
Micron: The Making Of A Margin King
about 9 hours agoMicron (MU) delivered blowout Q3 results on Wednesday, driven by surging demand for high bandwidth memory and DRAM, pushing gross margins to an...
Merck Germany Lands Bio-Techne In $11.3 Billion Cash Deal
about 9 hours agoMerck KGaA is acquiring Bio-Techne in an $11.3B all-cash deal to expand its life science, diagnostics, and bioprocessing footprint.
Scholar Rock Holding Corporation (SRRK) focuses on Apitegromab, a selective anti-latent myostatin antibody for Spinal Muscular Atrophy in patients age...
Cantor Fitzgerald Reiterates Overweight on COPT Defense Props, Maintains $37 Price Target
about 9 hours agoCantor Fitzgerald analyst Richard Anderson reiterates COPT Defense Props (NYSE:CDP) with a Overweight and maintains $37 price target.
Adobe Signs Agreement To Acquire Topaz Labs; Financial Terms Undisclosed
about 9 hours agoAdobe (NASDAQ:ADBE) — the global technology leader that unleashes creativity, productivity and customer experiences through innovative tools and platf...
MU Stock Rallies Premarket After Blowout Q3 Report: JPMorgan Nearly Triples Price Target On AI Demand Boom
about 9 hours agoMicron reported record numbers for its fiscal third quarter and indicated that rapid growth will be sustained over the next few years.
Costco's Cash Pile Is Building. Is a Special Dividend Coming in the Second Half of 2026?
about 9 hours agoWhen Costco pays a special dividend, it does it in a big way.
AirJoule (AIRJ) upgraded to Buy with $5.6 FY26 target.
Yiren Digital Ltd. 2026 Q1 - Results - Earnings Call Presentation
about 9 hours ago2026-06-25. The following slide deck was published by Yiren Digital Ltd.
ROKU INC (NASDAQ:ROKU) Screens as a High Growth Momentum Play with Strong Technical Setup
about 9 hours agoROKU stock combines high growth momentum with strong technicals, featuring 282% EPS growth, accelerating sales, and a bull flag pattern with a TA Rati...
Micron Technology, Inc. posts blowout Q3 as AI DRAM/NAND demand surges; guidance flags tight supply to 2027 and big EPS upside. Click for this MU earn...
Loading...
